Ventilator Associated Pneumonia. ICU Fellowship Training Radboudumc
|
|
- Lee Tyler Barker
- 5 years ago
- Views:
Transcription
1 Ventilator Associated Pneumonia ICU Fellowship Training Radboudumc
2 Attributable mortality VAP Meta-analysis of individual patient data from randomized prevention studies Attributable mortality mainly results from longer stay in the ICU Melsen WG. Lancet 2013
3
4 The problem Clinical criteria Antibiotics No antibiotics Sensitivity 69% Specificity 75% Selection multiresistant micro-organisms Inadequate treatment increases mortality The importance of quantitative cultures is not consistent
5 Incidence of VAP? Prospective cohort & nonrandomized trials (N = 38) Control arms in randomized trials (N = 51) Safdar N. Crit Care Med 2005;33:
6 ICU acquired infection Potential Pathogenic M.O. Reservoir Other patient Digestive tract Surroundings Colonisation Infection
7 Pathophysiology VAP N = 64 Tracheal aspirate 17 PPMO (85%) Gastric aspirate 6 PPMO (20%) Pneumonia N = PPMO Bonten MJ. Chest 1994;105:
8 Exogenous source Oral colonisation Endogenous source Accumulation of secretions above cuff Colonization of Trachea Pneumonia
9 Bed head elevation Niel-Weise BS. Crit Care 2011;15:R111
10 A group of 22 experts recommended elevating the head of the bed of mechanically ventilated patients to a 20 to 45 degrees position and preferably in a 30 degrees position as long as it does not pose risks or conflicts with other nursing tasks, medical interventions or patients wishes. Niel-Weise BS. Crit Care 2011;15:R111
11 ET modifications Silver sulfadiazine
12 Subglottic drainage N Control Study P-value Comment Mahul General ICU 29,1 13 < 0,05 No BAL or PSB Valles General ICU 39.6/ /1000 0,03 BAL/PSB Kollef Cardiac ICU 8,2% 5% 0,238 No BAL or PSB Smulders General ICU 16% 4% 0,014 No BAL or PSB Lorente General ICU 22,1% 7,9% 0,001 No BAL or PSB We recently finished a RCT on subglottic drainage after tracheostomy
13 Subglottic drainage 40 Subglottic drainage (n=169) p=0.02 Control (n=164) p=0.01 Incidence, % p= VAP total VAP early VAP late 6 ARR 11% < 5 days 5 days Lacherade JC. Am J Respir Crit Care Med 2010; 182:
14 Lacherade JC. Am J Respir Crit Care Med 2010; 182: Secondary outcomes , ,1 11,6 8,0 7,0 11,0 11,0 3 4,5 0 PED, % Tracheostomy, % MV, d LOS, d No difference in mortality
15 Subglottic drainage Reduces LOS and duration of MV but not mortality Muscedere J. Crit Care Med 2011
16 SDD and SOD NS 30 NS 27,5 26,6 26,9 Crude mortality (%) After correction for baseline differences absolute mortality reduction with SDD and SOD of 3.5 and 2.9% respectively 0 Control (N = 1990) SOD (N = 1904) SDD (N = 2045) de Smet AMGA. N Engl J Med 2009;360:20-31
17 Colonisation with resistant Gr- organisms 20 Ceftazidime - rectal isolates % colonised Time (months) Oostdijk EAN. Am J Respir Crit Care Med 2010;181:
18 Colonisation with BMRO de Smet AMGA. Lancet Inf Dis 2011
19 Oral decontamination and antibiotic resistance SDD SOD 30 P < P < 0.42 P < ,5 24,1 25,4 15 7,5 0 11,8 5,6 5,9 4,6 Aminogl resistant Gr - D 28 mortality Bacteremia N = In both groups gradual resistance increase Oostdijk EAN. JAMA 2014
20 SDD Meta-analysis SOD Chlorhexidine ( ) Favours SOD Favours Control ( ) ( ) Favours SDD Favours Control Favours SDD Favours Control Price R. BMJ 2014;348:g2197
21 Morrow LE. Am J Respir Crit Care Med 2010;182: Probiotics and VAP prevention RCT - N = oral/gastric Lactobaccilus rhamnosus 40 Probiotics Control P = P = VAP 0 Closttridium Difficile
22 Early vs late tracheotomy for VAP prevention N = 419 Early = 6-8 D Late = D Early Late P = VAP % 0 MV free days D 28 No difference in mortality JAMA 2010;303:
23 69% 57%
24 Diagnostic strategy in oncology patients with ARF Azoulay E. Am J Respir Crit Care Med 2010;182:
25 Conclusion In oncology patients with ARF early FO- BAL does not increase the need for MV Approximately 15-20% of diagnoses stems from FO-BAL Non-invasive strategy is very successful and likely so in the near future Up-to-date early FO-BAL still indicated but balance certainly shifted towards noninvasive strategy Azoulay E. Am J Respir Crit Care Med 2010;182:
26 Possible strategy Clinical suspicion CPIS > 6 (moderate sensitivity) Quantitative cultures Start antibioticics role of biomarkers appears limited after hours Diagnosis VAP likely Antibiotics 7-10 D PCT? Diagnosis VAP? Alternative diagnosis? Individual decission TREM- 1 VAP unlikely Stop antibiotics Fagon JY. Crit Care 2011;15:130
27 Antibiotic duration N = 401 Antibiotics 8 D Antibiotics 15 D 30 28, ,8 17, ,1 8,7 0 Mortality (%) Antibiotic free days (D) Recurrence (%) Higher relapse rate with pseudomonas and acinetobacter with shorter ab duration Chastre J. JAMA 2003;290:
28 Inhalation antibiotics First Phase II RCT of i.v. versus inhaled ceftazidime and amikacin N = 40 - VAP with susceptible or intermediate pseudomonas strains After 8 dyas of treatment success rate in inhalation group 70% and i.v. 55% (NS) Acquisition of resistance only in i.v. group Lu Q. Am J Respir Crit Care Med 2011;in press
29 Inhaled antibiotics and MDRO s Double-blind, randomized, placebo-controlled trial (N = 42) MV patients with high risk for MDRO Purulent sputum with + gram stain and CPIS 6 Placebo versus inhaled antibiotics (based on gram stain and/or amikacin) every 8 hrs for 14 D - systemic antibiotics by physician Palmer LB. Am J Respir Crit Care Med 2014;189:
30 Inhaled antibiotics and MDRO s Other MDRO 30 Number tracheal isolates at start Control 20 7 Inhaled antibiotics No. of eradicated organisms present at randomization No. of patients with eradication of resistant MO IA Placebo P-value 96% (26/27) 88% (14/16) 9% (2/23) < % (1/11) < Significantly less development of resistance to systemic antibiotics in inhaled antibiotics group Palmer LB. Am J Respir Crit Care Med 2014;189:
Ventilator Associated Pneumonia. ICU Fellowship Training Radboudumc
Ventilator Associated Pneumonia ICU Fellowship Training Radboudumc Attributable mortality VAP Meta-analysis of individual patient data from randomized prevention studies Attributable mortality mainly results
More informationDiagnosis of Ventilator- Associated Pneumonia: Where are we now?
Diagnosis of Ventilator- Associated Pneumonia: Where are we now? Gary French Guy s & St. Thomas Hospital & King s College, London BSAC Guideline 2008 Masterton R, Galloway A, French G, Street M, Armstrong
More informationVentilator Associated
Ventilator Associated Pneumonia: Key and Controversial Issues Christopher P. Michetti, MD, FACS Inova Fairfax Hospital, Falls Church, VA Forrest Dell Moore, MD, FACS Banner Healthcare System, Phoenix,
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY
HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health
More informationANWICU knowledge
ANWICU knowledge www.anwicu.org.uk This presenta=on is provided by ANWICU We are a collabora=ve associa=on of ICUs in the North West of England. Permission to provide this presenta=on has been granted
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION
HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health Care Medical
More informationVAP Definitions. CDC New Approach to VAP Surveillance. Conflict of Interest Disclosure Robert M Kacmarek. Artificial Airways, Cuffs, Bioflim and VAP
Conflict of Interest Disclosure Robert M Kacmarek Artificial Airways, Cuffs, Bioflim and VAP Bob Kacmarek PhD, RRT Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 9-14-18
More informationGuidelines 2017 for the management of hospitalacquired pneumonia (HAP) and. ventilator-associated. pneumonia (VAP)
Guidelines 2017 for the management of hospitalacquired pneumonia (HAP) and ventilator-associated Modifiez le style des sous-titres du masque pneumonia (VAP) Filip Moerman Présentation pour les soins int
More informationVAP Prevention bundles
VAP Prevention bundles Dr. Shafiq A.Alimad MD Head of medical department at USTH YICID workshop, 15-12-2014 Care Bundles What are they & why use them? What are Care Bundles? Types of Care Bundles available
More informationNew Surveillance Definitions for VAP
New Surveillance Definitions for VAP 2012 Critical Care Canada Forum Toronto Dr. John Muscedere Associate Professor of Medicine, Queen s University Kingston, Ontario Presenter Disclosure Dr. J. G. Muscedere
More informationYear in Review Intensive Care Training Program Radboud University Medical Centre Nijmegen
Year in Review 2013 Intensive Care Training Program Radboud University Medical Centre Nijmegen Contents ARDS Ventilator associated pneumonia Tracheostomy and endotracheal intubation Enteral feeding Fluid
More informationIntracheal antibiotics administration
Intracheal antibiotics administration Jean Chastre, M.D. www.reamedpitie.com Disclosure Conflicts of interest: Consulting or Lecture fees: Bayer, Pfizer, Cubist/Merck, Basilea, Kenta/Aridis, Roche, AstraZeneca/Medimmune
More informationAntisepsis Bath and Oral.. Should We Change Practice? DR AZMIN HUDA ABDUL RAHIM
Antisepsis Bath and Oral.. Should We Change Practice? DR AZMIN HUDA ABDUL RAHIM Chlorhexidine Exposure in ICU Chlorhexidine gluconate Long acting topical antiseptic In use since 1954 Water soluble Remains
More informationKIMBERLY-CLARK* MICROCUFF* Endotracheal Tube.. Revolutionary cuff material designed to reduce micro-aspiration
KIMBERLY-CLARK* MICROCUFF* Endotracheal Tube.. Revolutionary cuff material designed to reduce micro-aspiration Ventilator-Associated Pneumonia VAP is a major clinical concern...... associated with high
More informationAmerican College of Surgeons Critical Care Review Course 2012: Infection Control
American College of Surgeons Critical Care Review Course 2012: Infection Control Overview: I. Central line associated blood stream infection (CLABSI) II. Ventilator associated pneumonia (VAP) I. Central
More informationVentilator associated events, conditions and prevention of VAP. Dr.Pratap Upadhya
Ventilator associated events, conditions and prevention of VAP Dr.Pratap Upadhya Introduction Pathogenesis of vap Diagnosis of vap Ventilator-Associated Events: New Terminology and Its Relationship to
More informationSaudi Journal of Medical and Pharmaceutical Sciences. DOI: /sjmps. Review Article. Available Online:
DOI: 10.21276/sjmps Saudi Journal of Medical and Pharmaceutical Sciences Scholars Middle East Publishers Dubai, United Arab Emirates Website: http://scholarsmepub.com/ ISSN 2413-4929 (Print) ISSN 2413-4910
More informationJean CARLET, M.D. Head of the Research and Safety Program The French National Authority for Health (HAS)
ZERO VAP Dream, mystification, or reality? Jean CARLET, M.D. Head of the Research and Safety Program The French National Authority for Health (HAS) National Prevalence surveys 2 5 2 438 474 (95%) beds
More informationMechanical Ventilation
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 33: Mechanical Ventilation Authors C. Landelle, PharmD, PhD D. Pittet, MD, MS Chapter Editor Gonzalo Bearman, MD, MPH, FACP, FSHEA, FIDSA Topic Outline
More informationThe Potential For Microbiome Modification In Critical Illness. Deborah Cook
The Potential For Microbiome Modification In Critical Illness Deborah Cook To review Objectives The microbiome & concepts about its modification during critical illness Interventions Predisposition to
More informationMarcos I. Restrepo, MD, MSc, FCCP
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS for your personal use only, as submitted by the author.
More informationTHE MICROBIOLOGICAL PROFILE OF VENTILATOR ASSOCIATED PNEUMONIA.
THE MICROBIOLOGICAL PROFILE OF VENTILATOR ASSOCIATED PNEUMONIA. Dr. Poonam C. Sharma, Dr. S. S. Raut, Dr. S. R. More, Dr. V. S. Rathod, Dr. V. M. Gujar. 1. Post Graduate Student, Department of Microbiology,
More informationVentilator-associated pneumonia
Respirology (2009) 14 (Suppl. 2) S51 S58 doi: 10.1111/j.1400-1843.2009.01577.x CHAPTER VIII Ventilator-associated pneumonia SUMMARY Ventilator-associated pneumonia is a pneumonia that develops initially
More informationBIP Endotracheal Tube
Bactiguard Infection Protection BIP Endotracheal Tube For prevention of healthcare associated infections Ventilator associated pneumonia Infections of the respiratory tract are serious and common healthcare
More informationUsefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège
Usefulness of Procalcitonin in the management of Infections in ICU P Damas CHU Sart Tilman Liège Procalcitonin Peptide 116 AA Produced by parenchymal cells during «sepsis»: IL1, TNF, IL6 : stimulators
More informationA NEW direction for subglottic secretion management
A NEW direction for subglottic secretion management The SIMEX Subglottic Aspiration System, cuff M and cuff S are the most advanced solution for the aspiration of subglottic secretion, featuring all new
More informationFrom the labo to the ICU: Surveillance cultures in daily ICU practice. Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital
From the labo to the ICU: Surveillance cultures in daily ICU practice Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital Question 1: What is the current practice of surveillance cultures
More informationGuess or get it right?
Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders
More informationVentilator Associated Pneumonia: New for 2008
Ventilator Associated Pneumonia: New for 2008 Jeanine P. Wiener-Kronish, MD Henry Isaiah Dorr Professor of Research and Teaching in Anaesthetics and Anaesthesia Department of Anesthesia and Critical Care
More informationTargeted literature review:
Targeted literature review: What are the key infection prevention and control recommendations to inform a minimising ventilator associated pneumonia (VAP) quality improvement tool? Part of HAI Delivery
More informationPREVALENCE PATTERN OF MORBIDITY AND MORTALITY IN VENTILATION ASSOCIATED PNEUMONIA (VAP) PATIENTS OF INTENSIVE CARE UNIT (ICU) IN MAHARASHTRA REGION.
Original research article International Journal of Medical Science and Education pissn- 2348 4438 eissn-2349-3208 PREVALENCE PATTERN OF MORBIDITY AND MORTALITY IN VENTILATION ASSOCIATED PNEUMONIA (VAP)
More informationNosocomial Pneumonia. <5 Days: Non-Multidrug-Resistant Bacteria
Nosocomial Pneumonia Meredith Deutscher, MD Troy Schaffernocker, MD Ohio State University Burden of Hospital-Acquired Pneumonia Second most common nosocomial infection in the U.S. 5-10 episodes per 1000
More informationClinical Practice Management Guideline for Ventilator-Associated Pneumonia: Diagnosis, Treatment & Prevention
Clinical for Ventilator-Associated Pneumonia: Diagnosis, Treatment & Prevention Background Ventilator-associated pneumonia (VAP), a pneumonia that develops 48hrs after initiation of mechanical ventilation,
More informationCurrent Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics. Deborah Cook
Current Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics Deborah Cook Objectives VAP The Old: Gastropulmonary route of infection The New: Microbiome modification Role of acid suppression Influence
More informationChallenges in Diagnosis, Surveillance and Prevention of Ventilator-associated pneumonia
Challenges in Diagnosis, Surveillance and Prevention of Ventilator-associated pneumonia Massachusetts Coalition for the Prevention of Errors November 6, 2008 Michael Klompas MD, MPH, FRCPC Brigham and
More informationPreventing Nosocomial Pneumonia
Prevention of Nosocomial Pneumonia Andreas F. Widmer, MD,MS,FIDSA,FSHEA Chair Infection Control University of Basel Hospitals & Clinics Basel, Switzerland Preventing Nosocomial Pneumonia Definition & Surveillance
More informationCommunity Acquired & Nosocomial Pneumonias
Community Acquired & Nosocomial Pneumonias IDSA/ATS 2007 & 2016 Guidelines José Luis González, MD Clinical Assistant Professor of Medicine Outline Intro - Definitions & Diagnosing CAP treatment VAP & HAP
More informationVENTILATOR ASSOCIATED PNEUMONIA (VAP)
VENTILATOR ASSOCIATED PNEUMONIA (VAP) Dr.Kolli S.chalam, MD; PDCC. Prof. & Head Dept. of Anesthesiology and Critical care Medicine, Sri Sathya Sai Institute of Higher Medical Sciences, white field, Bangalore-560066.
More informationEffects of Systematic Oral Care in Critically Ill Patients: a Multicenter Study
Effects of Systematic Oral Care in Critically Ill Patients: a Multicenter Study NANCY J. AMES, RN, PhD, CCRN with Pawel Sulima, Jan M. Yates, Linda McCullagh, Sherri L. Gollins, Karen Soeken, and Gwenyth
More informationCHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement
CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement Evidence-Based Assessment of Diagnostic Tests for Ventilator- Associated Pneumonia* Executive Summary Ronald F. Grossman, MD, FCCP; and Alan Fein, MD,
More informationPrevention of Nosocomial Infections in Critically Ill Patients with Lactoferrin (PREVAIL) Study
Prevention of Nosocomial Infections in Critically Ill Patients with Lactoferrin (PREVAIL) Study A Randomized Double Blind Phase II Study Dr. John Muscedere, Queen s University, Kingston, Canada Co-Investigators:
More informationIS YOUR CUFF DOING THE JOB?
MICROCUFF * Endotracheal Tubes IS YOUR CUFF DOING THE JOB? Polyurethane cuff and subglottic secretion drainage help prevent early- and late-onset VAP 1 LEADING AUTHORITIES: SUBGLOTTIC SUCTIONING IS A BEST
More informationCross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit
Thorax 1998;53:1053 1058 1053 Internal Medicine, University Hospital Maastricht, Maastricht, The DCJJBergmans S van der Geest R M Wilting P W de Leeuw Internal Medicine, University Hospital Utrecht, Utrecht,
More informationThe use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and tracheobronchitis: a systematic review
Russell et al. BMC Pulmonary Medicine (2016) 16:40 DOI 10.1186/s12890-016-0202-8 RESEARCH ARTICLE Open Access The use of inhaled antibiotic therapy in the treatment of ventilator-associated pneumonia and
More informationVAP in COPD patients. Ignacio Martin-Loeches. St James s University Hospital. Trinity Centre for Health Sciences. Dublin Ireland.
VAP in COPD patients Ignacio Martin-Loeches St James s University Hospital. Trinity Centre for Health Sciences. Dublin Ireland. Outline Pathophysiology Is enough information? COPD trends in ICU How do
More informationDisclosure. Hospira Pharmaceuticals. Unrestricted research funding Honoraria for CME education administered via France Foundation
Disclosure Hospira Pharmaceuticals Unrestricted research funding Honoraria for CME education administered via France Foundation Economics in Sedation: Responsible Use of the ICU Budget John W. Devlin,
More informationBacteriological profile and outcome of Ventilator associated pneumonia in Intensive care unit of a tertiary care centre
ORIGINAL ARTICLE ASIAN JOURNAL OF MEDICAL SCIENCES Bacteriological profile and outcome of Ventilator associated pneumonia in Intensive care unit of a tertiary care centre Ravi K 1, Maithili TM 2, David
More informationVentilator-associated pneumonia
Topical chlorhexidine for prevention of ventilator-associated pneumonia: A meta-analysis* Maciej Piotr Chlebicki, MD; Nasia Safdar, MD, MS Objective: To assess the efficacy of topical chlorhexidine for
More informationJean-Yves Fagon,* Jean Chastre, Yves Domart, Jean-Louis Trnuillet, and Claude Gibert
538 Mortality Due to Ventilator-Associated Pneumonia or Colonization with Pseudomonas or Acinetobacter Species: Assessment by Quantitative Culture of Samples Obtained by a Protected Specimen Brush Jean-Yves
More informationThe promise of nebulized antibiotic therapy
1 st ATHENA International Conference Athens, 19-20 November 2015 Let s Talk About Inhaled Antibiotics Inhaled Antibiotics: The Story Stijn BLOT Dept. of Internal Medicine Faculty of Medicine & Health Science
More informationEnterobacter aerogenes
Enterobacter aerogenes Piagnerelli M 1, Carlier E 1, Deplano A 3, Lejeune P 1, Govaerts D 2 1 Departments of Intensive Care and 2 Microbiology, A. Vésale Hospital. 6110 Montigny-le-Tilleul. 3 Department
More informationCOPD exacerbation. Dr. med. Frank Rassouli
Definition according to GOLD report: - «An acute event - characterized by a worsening of the patients respiratory symptoms - that is beyond normal day-to-day variations - and leads to a change in medication»
More informationInhaled Antibiotics in Non-CF. Dr Michael Loebinger Host Defence Unit Royal Brompton Hospital London, United Kingdom
Inhaled Antibiotics in Non-CF Dr Michael Loebinger Host Defence Unit Royal Brompton Hospital London, United Kingdom Advantages Increased drug concentrations locally Reduced systemic adverse effects Home
More informationAerosolized Antibiotics in Mechanically Ventilated Patients
Aerosolized Antibiotics in Mechanically Ventilated Patients Gerald C Smaldone MD PhD Introduction Topical Delivery of Antibiotics to the Lung Tracheobronchitis Aerosolized Antibiotic Delivery in the Medical
More informationPepsin and amylase in oral and tracheal secretions of patients with standard versus continuous subglottic suctioning endotracheal tubes
University of Central Florida HIM 1990-2015 Open Access Pepsin and amylase in oral and tracheal secretions of patients with standard versus continuous subglottic suctioning endotracheal tubes 2012 Katherine
More informationEpidemiological and Microbiological Analysis of Ventilator-Associated Pneumonia Patients in a Public Teaching Hospital
482 BJID 2007; 11 (October) Epidemiological and Microbiological Analysis of Ventilator-Associated Pneumonia Patients in a Public Teaching Hospital João Manoel da Silva Júnior 1, Ederlon Rezende 1, Thaís
More informationArmamentarium to prevent VAP. Innovations in Endotracheal Tubes. Armamentarium to prevent VAP. Avoiding accumulation of subglottic secretions
Symposium Trends in de Spoedgevallen en Intensive Zorgen Thomas More Hogeschool, Mechelen, 17 mei 2018 Armamentarium to prevent VAP microaspiration Ventilator-Associated Pneumonia Innovations in Endotracheal
More informationP. aeruginosa: Present therapeutic options in Intensive Care. Y. Van Laethem (CHU St-Pierre & Université libre de Bruxelles, Brussels, Belgium)
P. aeruginosa: Present therapeutic options in Intensive Care Y. Van Laethem (CHU St-Pierre & Université libre de Bruxelles, Brussels, Belgium) Activity vs Pseudomonas aeruginosa Pseudomonas aeruginosa
More informationwithout the permission of the author Not to be copied and distributed to others
Emperor s Castle interior-prato What is the Role of Inhaled Polymyxins for Treatment of Respiratory Tract Infections? Helen Giamarellou CONCLUSIONS: Patients with Pseudomonas and Acinetobacter VAP may
More informationDo PPIs Reduce Bleeding in ICU? Revisiting Stress Ulcer Prophylaxis. Deborah Cook
Do PPIs Reduce Bleeding in ICU? Revisiting Stress Ulcer Prophylaxis Deborah Cook ICU-Acquired Upper GI Bleeding Case series of 300 ICU patients describing stressrelated erosive syndrome Frequent Fatal
More informationHerpes virus reactivation in the ICU. M. Ieven BVIKM
Herpes virus reactivation in the ICU M. Ieven BVIKM 07.04.2011 Introduction: Viruses identified in critically ill ICU patients Viral diseases have recently been the subject of numerous investigations in
More informationSurviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012
本檔僅供內部教學使用檔案內所使用之照片之版權仍屬於原期刊公開使用時, 須獲得原期刊之同意授權 Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 Definition Sepsis the presence of infection with
More informationLandmark articles on ventilation
Landmark articles on ventilation Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity ARDS AECC DEFINITION-1994 ALI Acute onset Bilateral chest infiltrates PCWP
More informationSelective decontamination of the digestive tract: an update of the evidence
Endorsed by proceedings in Intensive Care Cardiovascular Anesthesia review ArticlE HSR Proceedings in Intensive Care and Cardiovascular Anesthesia 2012; 4(1): 21-29 Selective decontamination of the digestive
More informationProbiotics for Primary Prevention of Clostridium difficile Infection
Probiotics for Primary Prevention of Clostridium difficile Infection Objectives Review risk factors for Clostridium difficile infection (CDI) Describe guideline recommendations for CDI prevention Discuss
More informationJournal Club The ELITE Trial. Sandra Katalinic, Pharmacy Resident University Hospital of Northern British Columbia April 28, 2010
Journal Club The ELITE Trial Sandra Katalinic, Pharmacy Resident University Hospital of Northern British Columbia April 28, 2010 Overview Journal article Title, journal, authors, funding Abstract Introduction
More informationInvasive Pulmonary Aspergillosis in
Infection & Sepsis Symposium Porto, April 1-3, 2009 Invasive Pulmonary Aspergillosis in Non-Immunocompromised Patients Stijn BLOT, PhD General Internal Medicine & Infectious Diseases Ghent University Hospital,
More informationPradeep Morar, MD; Zvoru Makura, MD; Andrew Jones, MD; Paul Baines, MD; Andrew Selby, MD; Julie Hughes, RGN; and Rick van Saene, MD
Topical Antibiotics on Tracheostoma Prevents Exogenous Colonization and Infection of Lower Airways in Children* Pradeep Morar, MD; Zvoru Makura, MD; Andrew Jones, MD; Paul Baines, MD; Andrew Selby, MD;
More informationHospital-acquired Pneumonia
Hospital-acquired Pneumonia Hospital-acquired pneumonia (HAP) Pneumonia that occurs at least 2 days after hospital admission. The second most common and the leading cause of death due to hospital-acquired
More informationPAPER DE LA VNI EN LA RETIRADA DE LA VENTILACIÓ INVASIVA I FRACÀS D EXTUBACIÓ
PAPER DE LA VNI EN LA RETIRADA DE LA VENTILACIÓ INVASIVA I FRACÀS D EXTUBACIÓ Dr. Miquel Ferrer UVIIR, Servei de Pneumologia, Hospital Clínic, IDIBAPS, CibeRes, Barcelona. E- mail: miferrer@clinic.ub.es
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for
More informationA new direction for subglottic secretion management. automated subglottic aspiration system simex cuff M & cuff S
A new direction for subglottic secretion management automated subglottic aspiration system simex cuff M & cuff S 02 03 About the company location Our company is located since more than years in Deißlingen,
More informationImpact of humidification and gas warming systems on ventilatorassociated
Online Data Supplement Impact of humidification and gas warming systems on ventilatorassociated pneumonia. Jean-Claude Lacherade, M.D. 1, Marc Auburtin, M.D. 2, Charles Cerf, M.D. 3, Andry Van de Louw,
More informationNovel preventive strategies for ventilatorassociated
REVIEW Novel preventive strategies for ventilatorassociated pneumonia Andrea Coppadoro 1 *, Edward Bittner 2 and Lorenzo Berra 2 This article is one of eleven reviews selected from the Annual Update in
More informationKingdom; 2 University of Cambridge, Cambridge, United Kingdom
P-111 TIMING OF TRACHEOSTOMY AND ASSOCIATED COMPLICATIONS IN CARDIOTHORACIC INTENSIVE CARE PATIENTS Zochios, Vasileios 1 ; Casey, Jessica 2 ; Vuylsteke, Alain 1 1 Cardiac Critical Care Unit, Papworth Hospital
More informationSepsis is an important issue. Clinician s decision-making capability. Guideline recommendations
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012 Clinicians decision-making capability Guideline recommendations Sepsis is an important issue 8.7%
More informationNIV in hypoxemic patients
NIV in hypoxemic patients Massimo Antonelli, MD Dept. of Intensive Care & Anesthesiology Università Cattolica del Sacro Cuore Rome - Italy Conflict of interest (research grants and consultations): Maquet
More informationAntimicrobial Stewardship in Community Acquired Pneumonia
Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis
More informationInfluence of an Endotracheal Tube with Polyurethane Cuff and Subglottic Secretion Drainage on Pneumonia
Influence of an Endotracheal Tube with Polyurethane Cuff and Subglottic Secretion Drainage on Pneumonia Leonardo Lorente 1, María Lecuona 2, Alejandro Jiménez 3, María L. Mora 4, and Antonio Sierra 5 1
More informationConflicts of Interest. Learning Objectives VAP. Common Organisms. Risk Factors for VAP. Gram Positive 10/13/2017
Conflicts of Interest The author has no conflicts of interest to disclose Nebulized Antibiotics in VAP: Don t Hold Your Breath Luis M. Ramirez, Pharm.D. PGY1 Pharmacy Practice Resident University of Texas
More informationGET THE. Suction port. Subglottic secretions. VAP incidence and mortality. Pathogenesis and risk factors. Subglottic secretions drainage (SSD)
GET THE FACTS The facts about ventilator-associated pneumonia () and subglottic secretions drainage (SSD) incidence and mortality is the second most common nosocomial infection in the United States. It
More informationWEANING READINESS & SPONTANEOUS BREATHING TRIAL MONITORING
CLINICAL EVIDENCE GUIDE WEANING READINESS & SPONTANEOUS BREATHING TRIAL MONITORING Weaning readiness and spontaneous breathing trial monitoring protocols can help you make the right weaning decisions at
More informationThe perfidious effect of topical placebo: A calibration of Staphylococcus aureus. Ventilator Associated Pneumonia incidence within Selective Digestive
AAC Accepts, published online ahead of print on 8 July 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.00424-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. - 1-1 2 3 The
More informationWhy we need inhaled antibiotics?
Athens 19-20 November 2015 Why we need inhaled antibiotics? Garyfallia Poulakou Consultant, Infectious Diseases 4 th Dept of Internal Medicine, Attikon University Hospital of Athens TRANSPARENCY DECLARATION
More informationContinuous Infusion of Antibiotics In The ICU: What Is Proven? Professor of Medicine Vice-Chairman, Department of Medicine SUNY at Stony Brook
Continuous Infusion of Antibiotics In The ICU: What Is Proven? Michael S. Niederman, M.D. Chairman, Department of Medicine Winthrop-University Hospital Mineola, NY Professor of Medicine Vice-Chairman,
More informationInfluence of changing endotracheal tube cuff management on antibiotic use for ventilator-associated pneumonia in a tertiary intensive care unit
Influence of changing endotracheal tube cuff management on antibiotic use for ventilator-associated pneumonia in a tertiary intensive care unit Jai N Darvall, Irani Thevarajan, Simon Iles, Thomas Rechnitzer,
More informationRethinking Arterial Catheters in the ICU. Allan Garland, MD, MA Professor of Medicine & Community Health Sciences University of Manitoba
Rethinking Arterial Catheters in the ICU Allan Garland, MD, MA Professor of Medicine & Community Health Sciences University of Manitoba No Conflicts of Interest Introduction The only appropriate rationale
More informationResearch & Reviews of. Pneumonia
Chapter Clinical Presentation and Diagnosis of VAP in Adult ICU Patients Priyam Batra * ; Purva Mathur Research & Reviews of Department of Laboratory Medicine, AIIMS, Trauma Centre, New Delhi, India. *
More informationSmall Chest Tubes May Be Sufficient for Empyema Tx
Small Chest Tubes May Be Sufficient for Empyema Tx The Relationship Between Chest Tube Size and Clinical Outcome in Pleural Infection. Rahman NM, Maskell NA, et al: Chest 2010; 137 (March): 536-543 In
More informationSupplementary Online Content 2
Supplementary Online Content 2 van Meenen DMP, van der Hoeven SM, Binnekade JM, et al. Effect of on demand vs routine nebulization of acetylcysteine with salbutamol on ventilator-free days in intensive
More informationBrice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine
Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine Discuss advances in predicting prognosis Understand dwhat we know (and don t know) about the Microbiology Recognize important
More informationVENTILATOR-ASSOCIATED pneumonia (VAP) is the
Ventilator-Associated Pneumonia: Incidence, Risk Factors, Outcome, and Microbiology Mandakini Pawar, BSc, Yatin Mehta, MD, DNB, FRCA, FAMS, Poonam Khurana, MD, Anshumali Chaudhary, MD, Vinay Kulkarni,
More informationPERFORMANCE UNDER PRESSURE.
PERFORMANCE UNDER PRESSURE. IntelliCuff Cuff Pressure Controller and SubG Endotracheal Tube Smart technology to help reduce risk of VAP and tracheal injuries Replace Complexity with Efficiency. Managing
More information5.4 Strategies to optimize delivery and minimize risks of Enteral Nutrition: Body position January 31 st, 2009
5.4 Strategies to optimize delivery and minimize risks of Enteral Nutrition: Body position January 31 st, 2009 Recommendation: Based on 1 level 1 and 1 level 2 study, we recommend that critically ill patients
More informationEUROANESTHESIA 2007 Munich, Germany, 9-12 June RC4
POSTOPERATIVE PNEUMONIA EUROANESTHESIA 2007 Munich, Germany, 9-12 June 2007 12RC4 HERVÉ DUPONT Anaesthesiology and Intensive Care Medicine North University Hospital Amiens, France Saturday Jun 9, 2007
More informationGUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 47: Carbapenem-resistant Enterobacteriaceae Authors E-B Kruse, MD H. Wisplinghoff, MD Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key Issue Known
More informationVentilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2006, p. 637 657 Vol. 19, No. 4 0893-8512/06/$08.00 0 doi:10.1128/cmr.00051-05 Copyright 2006, American Society for Microbiology. All Rights Reserved. Ventilator-Associated
More informationISF criteria (International sepsis forum consensus conference of infection in the ICU) Secondary peritonitis
Appendix with supplementary material. This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Supplementary Tables Table S1. Definitions
More informationInhalational antibacterial regimens in non-cystic fibrosis patients. Jeff Alder Bayer HealthCare
Inhalational antibacterial regimens in non-cystic fibrosis patients Jeff Alder Bayer HealthCare Alder - Inhaled therapy for non-cf - EMA 25-26 Oct 2012 1 Inhalational antibacterials: two approaches 1.
More information